跳至主要内容
临床试验/CTRI/2018/08/015533
CTRI/2018/08/015533已完成2 期

â??An Open Clinical Study to Evaluate the Efficacy of Shirobasti and Nasya With and Without Levodopa in the Management of Kampavata w.s.r. to Parkinsonâ??s Disease (PD).

ational Institute of Ayurveda0 个研究点目标入组 27 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients between 40-70 years of age.
  • 2.Patients with clinical signs and symptoms of Kampavata/ PD.
  • 3.Patients of either sex irrespective of their occupation, religion and socio-economic status.
  • 4.Patients of kampavata/PD who are on a fixed dose of levodopa and fit for Shirobasti and Nasya.
  • 5.Patients of kampavata/PD who are not on levodopa and fit for Shirobasti and Nasya.
  • 6.Patients willing to participate for interventional study.

排除标准

  • 1.Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem, Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, malignant disease etc.
  • 2.Patients unfit for Shirobasti and Nasya.

研究者

相似试验